UTILITY OF METABOLOMIC BIOMARKERS TO IDENTIFY NONALCOHOLIC FATTY LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS

被引:0
|
作者
Mowry, Christopher J.
Rinella, Mary E.
Iruarrizaga-Lejarreta, Marta
Alonso, Cristina
Ortiz, Pablo
Levitsky, Josh
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1456
引用
收藏
页码:S1410 / S1410
页数:1
相关论文
共 50 条
  • [1] Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
    Mowry, Christopher J.
    Alonso, Cristina
    Iruarrizaga-Lejarreta, Marta
    Ortiz, Pablo
    Levitsky, Josh
    Rinella, Mary
    [J]. TRANSPLANTATION DIRECT, 2021, 7 (12): : E784
  • [2] Utility of metabolomic biomarkers to identify non-alcoholic fatty liver disease in liver transplant recipients
    Mowry, Christopher
    Levitsky, Josh
    Alonso, Cristina
    Iruarrizaga-Lejarreta, Marta
    Pablo, Ortiz
    Rinella, Mary
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S428 - S428
  • [3] Metabolomics approaches to identify biomarkers of nonalcoholic fatty liver disease
    McGlinchey, Aidan
    Geng, Dawei
    Govaere, Olivier
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Schattenberg, Joern M.
    Daly, Ann K.
    Hyotylainen, Tuulia
    Anstee, Quentin
    Oresic, Matej
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S438 - S438
  • [4] Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients
    Siddiqui, Mohammad Shadab
    Parmar, Deven
    Shaikh, Farheen
    Forsgren, Mikael
    Patel, Samarth
    Bui, Anh Tuan
    Boyett, Sherry
    Patel, Vaishali
    Sanyal, Arun J.
    [J]. LIVER TRANSPLANTATION, 2023, 29 (09) : 979 - 986
  • [5] Biomarkers in nonalcoholic fatty liver disease
    Neuman, Manuela G.
    Cohen, Lawrence B.
    Nanau, Radu M.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 28 (11) : 607 - 618
  • [6] NONALCOHOLIC FATTY LIVER DISEASE IN RENAL TRANSPLANT RECIPIENTS PROVEN BY TRANSIENT
    Mikolasevic, Ivana
    Racki, Sanjin
    Lukenda, Vesna
    Persic, Martina Pavletic
    Colic, Marina
    Devcic, Bosiljka
    Orlic, Lidija
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 324 - 325
  • [7] Nonalcoholic Fatty Liver Disease after Liver Transplant
    Shetty, Akshay
    Giron, Fanny
    Divatia, Mukul K.
    Ahmad, Muhammad, I
    Kodali, Sudha
    Victor, David
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 428 - 435
  • [8] RADIOMICS BASED CORONARY HEART DISEASE SIGNATURE IN LIVER TRANSPLANT RECIPIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Syed, Taseen
    Forsgren, Mikael F.
    Bhati, Chandra
    Patel, Samarth
    Wolver, Susan
    Carper, Moriah C.
    Linge, Jennifer
    Leinhard, Olof Dahlqvist
    Miller, Austin
    Kirkman, Danielle L.
    Siddiqui, Mohammad S.
    [J]. HEPATOLOGY, 2021, 74 : 902A - 902A
  • [9] Cardiovascular and Metabolic Risk Profile of Nonalcoholic Fatty Liver Disease Patients and Liver Transplant Recipients
    An, Kyungeh
    Salyer, Jeanne
    Siddiqui, Shadab
    [J]. CIRCULATION, 2018, 138
  • [10] Fatty acid metabolites as biomarkers for nonalcoholic fatty liver disease (NAFLD): A lipidomic and metabolomic approach
    Hou, S.
    Li, Z.
    Zhou, Y. H.
    Meng, T.
    Zhu, M. G.
    Yin, H. Y.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S244 - S245